Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Comment on PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- Contributors:
University of Maryland; Imperial College London; Oregon Health and Science University; University of Chester; University of Michigan; University of Southern California; University of Navarra; MD Anderson Cancer Center; University of Newcastle
- بيانات النشر:
American Association for the Advancement of Science
- الموضوع:
2021
- Collection:
University of Chester: Chester Digital Repository
- نبذة مختصرة :
This article is not available on ChesterRep. ; LB100 does not sensitize CML stem cells to tyrosine kinase inhibitor–induced apoptosis.
- ISSN:
1946-6234
1946-6242
- Relation:
Perrotti, D., Agarwal, A., Lucas, C. M., Narla, G., Neviani, P., Odero, M. D., . & Verrills, N. M. (2019). Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”. Science translational medicine, 11(501), eaau0416. https://doi.org/10.1126/scitranslmed.aau0416; http://hdl.handle.net/10034/624385; Science Translational Medicine
- الرقم المعرف:
10.1126/scitranslmed.aau0416
- Rights:
CC0 1.0 Universal ; https://creativecommons.org/licenses/by-nc-nd/4.0/
- الرقم المعرف:
edsbas.EBB4A429
No Comments.